Kymera Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Kymera Therapeutics's estimated annual revenue is currently $19.2M per year.
- Kymera Therapeutics's estimated revenue per employee is $155,000
- Kymera Therapeutics has 124 Employees.
- Kymera Therapeutics grew their employee count by 85% last year.
- Kymera Therapeutics currently has 1 job openings.
What Is Kymera Therapeutics?
Kymera Therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. We are advancing the field of targeted protein degradation, accessing the bodyâ€™s innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. Powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients. Learn more at kymeratx.com.keywords:N/A